Free Trial

Bright Minds Biosciences (DRUG) Institutional Ownership

Bright Minds Biosciences logo
$43.27 +4.47 (+11.52%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$43.32 +0.05 (+0.13%)
As of 09/3/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Bright Minds Biosciences (NASDAQ:DRUG)

Current
Institutional Ownership
Percentage
40.52%
Number of
Institutional Buyers
(last 12 months)
23
Total
Institutional Inflows
(last 12 months)
$80.54M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$18.05M
Get DRUG Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bright Minds Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

DRUG Institutional Buying and Selling by Quarter

Bright Minds Biosciences Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Perceptive Advisors LLC420,690$10.98M1.0%-5.4%5.976%
8/15/2025 Bank of America Corp DE4,734$124K0.0%-12.6%0.067%
8/14/2025 Acuta Capital Partners LLC48,474$1.27M1.8%-18.9%0.688%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2,513$66K0.0%N/A0.036%
8/13/2025 Walleye Capital LLC53,430$1.40M0.0%-37.2%0.759%
8/13/2025 Sio Capital Management LLC512,338$13.38M5.1%+0.9%7.278%
8/13/2025 New York State Common Retirement Fund4,100$107K0.0%N/A0.058%
8/12/2025 JPMorgan Chase & Co.2,173$57K0.0%+624.3%0.031%
8/8/2025 Police & Firemen s Retirement System of New Jersey1,079$28K0.0%N/A0.015%
8/8/2025 Geode Capital Management LLC57,521$1.50M0.0%N/A0.817%
8/4/2025 AdvisorShares Investments LLC14,481$378K0.1%+28.4%0.206%
6/27/2025 Goldman Sachs Group Inc.22,222$802K0.0%N/A0.316%
5/16/2025 Goldman Sachs Group Inc.22,222$802K0.0%N/A0.315%
5/16/2025 Millennium Management LLC192,557$6.95M0.0%+376.9%2.734%
5/16/2025 Adage Capital Partners GP L.L.C.200,000$7.21M0.0%+50.9%2.839%
5/15/2025 RA Capital Management L.P.206,427$7.45M0.1%-55.2%2.931%
5/15/2025 OMERS ADMINISTRATION Corp14,000$505K0.0%N/A0.199%
5/14/2025 Walleye Capital LLC85,022$3.07M0.0%-17.6%1.207%
2/17/2025 Point72 Asset Management L.P.135,189$4.87M0.0%N/A3.049%
2/17/2025 Millennium Management LLC40,379$1.45M0.0%N/A0.911%
2/17/2025 Janus Henderson Group PLC508,776$18.39M0.0%N/A11.485%
2/17/2025 Bank of America Corp DE4,793$173K0.0%N/A0.108%
2/17/2025 Acuta Capital Partners LLC69,124$2.49M2.5%N/A1.560%
2/14/2025 RA Capital Management L.P.460,829$16.60M0.2%N/A10.402%
2/14/2025 Jane Street Group LLC6,600$238K0.0%N/A0.149%
2/14/2025 Schonfeld Strategic Advisors LLC69,812$2.47M0.0%N/A1.576%
2/14/2025 AdvisorShares Investments LLC3,075$111K0.0%-98.3%0.069%
2/14/2025 Boothbay Fund Management LLC44,580$1.61M0.0%N/A1.006%
2/14/2025 Adage Capital Partners GP L.L.C.132,500$4.77M0.0%N/A2.991%
2/14/2025 Vivo Capital LLC251,572$9.06M1.0%N/A5.679%
2/13/2025 Walleye Capital LLC103,192$3.72M0.0%N/A2.327%
2/13/2025 Springhill Fund Asset Management HK Co Ltd60,648$2.19M3.5%N/A1.369%
2/13/2025 Atika Capital Management LLC15,000$540K0.1%N/A0.339%
2/14/2024 AdvisorShares Investments LLC188,119$273K0.1%+12.0%4.246%
11/6/2023 AdvisorShares Investments LLC167,930$267K0.1%-67.4%4.452%
8/9/2023 AdvisorShares Investments LLC515,315$294K0.1%+14.7%14.640%
5/9/2023 AdvisorShares Investments LLC449,155$198K0.1%+42.7%2.553%
8/8/2022 AdvisorShares Investments LLC289,576$237K0.1%+40.1%2.439%
5/9/2022 AdvisorShares Investments LLC206,716$314K0.1%+115.5%1.745%
2/9/2022 Checchi Capital Advisers LLC14,138$45K0.0%N/A0.119%
Free: The Crypto Summit That Could Change Your Life (Ad)

27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your spot for FREE.tc pixel

Click here to reserve your free seat at the Crypto Community Summit
1/31/2022 AdvisorShares Investments LLC95,942$304K0.0%N/A0.810%
(Data available from 1/1/2016 forward)

DRUG Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DRUG shares?

During the previous two years, 24 institutional investors and hedge funds held shares of Bright Minds Biosciences. The most heavily invested institutionals were Janus Henderson Group PLC ($18.39M), Sio Capital Management LLC ($13.38M), Perceptive Advisors LLC ($10.98M), Vivo Capital LLC ($9.06M), RA Capital Management L.P. ($7.45M), Adage Capital Partners GP L.L.C. ($7.21M), and Millennium Management LLC ($6.95M).Learn more on Bright Minds Biosciences' institutional investors.

What percentage of Bright Minds Biosciences' stock is owned by institutional investors?

40.52% of Bright Minds Biosciences' stock is owned by institutional investors. Learn more on DRUG's institutional investor holdings.

Which institutional investors have been buying Bright Minds Biosciences' stock?

Of the 23 institutional investors that purchased Bright Minds Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($508.78K), RA Capital Management L.P. ($460.83K), Vivo Capital LLC ($251.57K), Adage Capital Partners GP L.L.C. ($200K), Millennium Management LLC ($192.56K), Point72 Asset Management L.P. ($135.19K), and Walleye Capital LLC ($103.19K).

How much institutional buying is happening at Bright Minds Biosciences?

Institutional investors have bought a total of 2,256,178 shares in the last 24 months. This purchase volume represents approximately $80.54M in transactions.

Which of Bright Minds Biosciences' major shareholders have been selling company stock?

The following institutional investors have sold Bright Minds Biosciences stock in the last 24 months: RA Capital Management L.P. ($254.40K), AdvisorShares Investments LLC ($179.35K), Walleye Capital LLC ($49.76K), Perceptive Advisors LLC ($23.96K), Acuta Capital Partners LLC ($11.27K), and Bank of America Corp DE ($682.00).

How much institutional selling is happening at Bright Minds Biosciences?

Institutional investors have sold a total of 519,424 shares in the last 24 months. This volume of shares sold represents approximately $18.05M in transactions.



This page (NASDAQ:DRUG) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners